We innovatively validate that EIF4A3‐triggered circDHTKD1 upregulation facilitates NSCLC glycolysis through recruiting m6A reader IGF2BP2 to stabilize PFKL, providing a new direction for seeking targeted therapy plans of NSCLC. Here, EIF4A3 is linked to non-small cell lung carcinoma.